foxo4-dri peptide human clinical trial Senolytic Selectively Removes Senescent Cells From in vitro Expanded Chondrocytes FOXO4 D-Retro-Inverso(DRI) peptide
FOXO4 D Retro Inverso(DRI) peptide Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI Peptide 10 mg FOXO4 DRI 10mg FOXO4 DRI 99% Purity, COA Included Glow Peptides
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




